High dose testosterone (T) treatment has no adverse effects on the endometrium of Female to Male transsexuals (FtM).

Testosterone (T) and estradiol (E2) therapy alone can suppress gonadal function in transgender patients.

Pappas, India I
Craig, Wendy Y
Spratt, Lindsey V
Spratt, Daniel I

April 2020

Suppression of endogenous gonadal function is an important goal of transgender hormone therapy in bo...

Repeated intramuscular injections of testosterone undecanoate (TU) in FtM transsexuals.

July 2015

none6noneF. Armillotta; M. Berra; A. Costantino; S. Cerpolini; G. Pelusi; M.C. Meriggiola.F. Armillo...

Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European Network for the Investigation of Gender Incongruence

Wierckx, Katrien
Van Caenegem, Eva
Schreiner, Thomas
Haraldsen, Ira
Fisher, Alessandra
Toye, Kaatje
Kaufman, Jean
T'Sjoen, Guy

January 2014

Introduction. Data on the effects of cross-sex hormone therapy (CHT) are limited due to the low prev...

Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals

Perrone, Anna Myriam
Cerpolini, Silvia
Maria Salfi, Nunzio Cosimo
Ceccarelli, Claudio
De Giorgi, Lucilla Badiali
Formelli, Guido
Casadio, Paolo
Pelusi, Giuseppe
Pelusi, Carla
Meriggiola, Maria Cristina
GHI, Tullio

January 2009

Introduction. Long term safety of testosterone (T) administration in women is still unknown. In part...

Testosterone Undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male (FtM) transsexuals: hormonal and metabolic effects.

July 2015

none9noneF. Armillotta; A. Costantino; S. Cerpolini; M. Berra; A.M. Perrone; F. De Musso; F. Saad; G...

Effects of testosterone undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male transsexuals (FtM):

July 2015

none9noneM.C. Meriggiola; F. Armillotta; P. Altieri; A. Costantino; S. Cerpolini; M. Berra; A.M. per...

Metabolic effects of 6-month testosterone administration in female to male (FtM) transsexuals

July 2015

none6noneA. Costantino; F. Armillotta; L. D'Emidio; S. Cerpolini; G. Pelusi; M.C. MeriggiolaA. Costa...

Effects of Testosterone Undecanoate (TU) Administered Alone or in Combination with Letrozole or Dutasteride in Female to Male (FtM) Transsexuals.

July 2015

none10noneM.C. Meriggiola; F. Armillotta; A. Costantino; P. Altieri; F. Saad; T.F. Kalhorn; A.M. Per...

Safety of testosterone (T) administration in women.

July 2015

none6noneM.C. Meriggiola; A.M. Perrone; S. Cerpolini; F. Armillotta; A. Costantino; G. Pelusi.M.C. M...

Effect of different testosterone formulations on body weight, body composition and metabolism in Female to Male (FtM) transsexuals.

July 2015

none5nonePelusi C.; Costantino A.; Cerpolini S.; Pelusi G.; Meriggiola M.C.Pelusi C.; Costantino A.;...

Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals

LOVERRO, Giuseppe
RESTA, Leonardo
DELLINO, MIRIAM
DI NARO, Edoardo
CASCARANO, MARIA ARCANGELA
Loverro, Matteo
MASTROLIA, SALVATORE ANDREA

January 2016

Objective Female-to-male transition remains a specific clinical indication for long-term testosteron...

Cross-sex hormone administration changes pain in transsexual women and men.

July 2015

none7noneAloisi A.M.; Bachiocco V.; Costantino A.; Stefani R.; Ceccarelli I.; Bertaccini A.; Meriggi...

Effects of Three Different Testosterone Formulations in Female-to-Male Transsexual Persons.

July 2015

none9noINTRODUCTION: Gender dysphoria is characterized by a strong discomfort with the gender assig...

Intima-Media wall thickness is increased in FtM transsexuals treated with testosterone compared to normal control women.

July 2015

none7noneM.C. Meriggiola; A. Costantino; F. Armillotta; M. Berra; G. Pelusi; S. Cerpolini; L. D'Emid...

Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals

Loverro, Giuseppe
Resta, Leonardo
Dellino, Miriam
Edoardo, Di Naro
Cascarano, Maria Arcangela
Loverro, Matteo
Mastrolia, Salvatore Andrea

October 2016

AbstractObjectiveFemale-to-male transition remains a specific clinical indication for long-term test...

Testosterone (T) and estradiol (E2) therapy alone can suppress gonadal function in transgender patients.

Pappas, India I
Craig, Wendy Y
Spratt, Lindsey V
Spratt, Daniel I

April 2020

Suppression of endogenous gonadal function is an important goal of transgender hormone therapy in bo...

Repeated intramuscular injections of testosterone undecanoate (TU) in FtM transsexuals.

July 2015

none6noneF. Armillotta; M. Berra; A. Costantino; S. Cerpolini; G. Pelusi; M.C. Meriggiola.F. Armillo...

Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European Network for the Investigation of Gender Incongruence

Wierckx, Katrien
Van Caenegem, Eva
Schreiner, Thomas
Haraldsen, Ira
Fisher, Alessandra
Toye, Kaatje
Kaufman, Jean
T'Sjoen, Guy

January 2014

Introduction. Data on the effects of cross-sex hormone therapy (CHT) are limited due to the low prev...

Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals

Perrone, Anna Myriam
Cerpolini, Silvia
Maria Salfi, Nunzio Cosimo
Ceccarelli, Claudio
De Giorgi, Lucilla Badiali
Formelli, Guido
Casadio, Paolo
Pelusi, Giuseppe
Pelusi, Carla
Meriggiola, Maria Cristina
GHI, Tullio

January 2009

Introduction. Long term safety of testosterone (T) administration in women is still unknown. In part...

Testosterone Undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male (FtM) transsexuals: hormonal and metabolic effects.

July 2015

none9noneF. Armillotta; A. Costantino; S. Cerpolini; M. Berra; A.M. Perrone; F. De Musso; F. Saad; G...

Effects of testosterone undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male transsexuals (FtM):

July 2015

none9noneM.C. Meriggiola; F. Armillotta; P. Altieri; A. Costantino; S. Cerpolini; M. Berra; A.M. per...

Metabolic effects of 6-month testosterone administration in female to male (FtM) transsexuals

July 2015

none6noneA. Costantino; F. Armillotta; L. D'Emidio; S. Cerpolini; G. Pelusi; M.C. MeriggiolaA. Costa...

Effects of Testosterone Undecanoate (TU) Administered Alone or in Combination with Letrozole or Dutasteride in Female to Male (FtM) Transsexuals.

July 2015

none10noneM.C. Meriggiola; F. Armillotta; A. Costantino; P. Altieri; F. Saad; T.F. Kalhorn; A.M. Per...

Safety of testosterone (T) administration in women.

July 2015

none6noneM.C. Meriggiola; A.M. Perrone; S. Cerpolini; F. Armillotta; A. Costantino; G. Pelusi.M.C. M...

Effect of different testosterone formulations on body weight, body composition and metabolism in Female to Male (FtM) transsexuals.

July 2015

none5nonePelusi C.; Costantino A.; Cerpolini S.; Pelusi G.; Meriggiola M.C.Pelusi C.; Costantino A.;...

Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals

LOVERRO, Giuseppe
RESTA, Leonardo
DELLINO, MIRIAM
DI NARO, Edoardo
CASCARANO, MARIA ARCANGELA
Loverro, Matteo
MASTROLIA, SALVATORE ANDREA

January 2016

Objective Female-to-male transition remains a specific clinical indication for long-term testosteron...

Cross-sex hormone administration changes pain in transsexual women and men.

July 2015

none7noneAloisi A.M.; Bachiocco V.; Costantino A.; Stefani R.; Ceccarelli I.; Bertaccini A.; Meriggi...

Effects of Three Different Testosterone Formulations in Female-to-Male Transsexual Persons.

July 2015

none9noINTRODUCTION: Gender dysphoria is characterized by a strong discomfort with the gender assig...

Intima-Media wall thickness is increased in FtM transsexuals treated with testosterone compared to normal control women.

July 2015

none7noneM.C. Meriggiola; A. Costantino; F. Armillotta; M. Berra; G. Pelusi; S. Cerpolini; L. D'Emid...

Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals

Loverro, Giuseppe
Resta, Leonardo
Dellino, Miriam
Edoardo, Di Naro
Cascarano, Maria Arcangela
Loverro, Matteo
Mastrolia, Salvatore Andrea

October 2016

AbstractObjectiveFemale-to-male transition remains a specific clinical indication for long-term test...

Testosterone (T) and estradiol (E2) therapy alone can suppress gonadal function in transgender patients.

Pappas, India I
Craig, Wendy Y
Spratt, Lindsey V
Spratt, Daniel I

April 2020

Suppression of endogenous gonadal function is an important goal of transgender hormone therapy in bo...

Repeated intramuscular injections of testosterone undecanoate (TU) in FtM transsexuals.

July 2015

none6noneF. Armillotta; M. Berra; A. Costantino; S. Cerpolini; G. Pelusi; M.C. Meriggiola.F. Armillo...

Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European Network for the Investigation of Gender Incongruence

Wierckx, Katrien
Van Caenegem, Eva
Schreiner, Thomas
Haraldsen, Ira
Fisher, Alessandra
Toye, Kaatje
Kaufman, Jean
T'Sjoen, Guy

January 2014

Introduction. Data on the effects of cross-sex hormone therapy (CHT) are limited due to the low prev...

High dose testosterone (T) treatment has no adverse effects on the endometrium of Female to Male transsexuals (FtM).

Abstract

Extracted data

High dose testosterone (T) treatment has no adverse effects on the endometrium of Female to Male transsexuals (FtM).

Abstract

Extracted data

Related items

Related items